High stromal carbonic anhydrase ix expression is associated with decreased survival in p16-negative head-and-neck tumors

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 1, 2011, Pages 249-257

  Brockton, Nigel ^a,b   Dort, Joseph ^b   Lau, Harold ^b   Hao, Desiree ^b   Brar, Sony ^a   Klimowicz, Alexander ^b   Petrillo, Stephanie ^b   Diaz, Roman ^b   Doll, Corinne ^b   Magliocco, Anthony ^b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Carbonic anhydrase IX; Human papilloma virus; Hypoxia; Squamous cell carcinoma; Stroma

Indexed keywords

GLUCOSE TRANSPORTER-1; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; HEAD-AND-NECK TUMOR; HUMAN PAPILLOMA VIRUS; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOSTAINING; IN-SITU HYBRIDIZATION; OVERALL SURVIVAL; OXYGEN MEASUREMENTS; RISK FACTORS; SEMI-QUANTITATIVE; SQUAMOUS CELL CARCINOMA; STROMA; THERAPEUTIC STRATEGY; TISSUE MICROARRAYS; TREATMENT FAILURE; TUMOR HYPOXIA; TUMOR TISSUES;

CHEMOTHERAPY; DIAGNOSIS; ENZYME INHIBITION; GLUCOSE; OXYGEN; OXYGEN SENSORS; POLYMERASE CHAIN REACTION; TUMORS; VIRUSES;

CARBONIC ANHYDRASE;

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; PROTEIN P16;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; OXIMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SQUAMOUS CELL CARCINOMA; STROMA; TISSUE MICROARRAY; WART VIRUS;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; TISSUE ARRAY ANALYSIS;

EID: 79953871071     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.059     Document Type: Article

References (67)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. C.C.R. Ragin, E. Taioli, and J.L. Weissfeld 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours Br J Cancer 95 2006 1432 1438 (Pubitemid 44760098)
3. M.L. Gillison, G. D'Souza, and W. Westra Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 2008 407 420 (Pubitemid 351480511)
4. J.A. Ernster, C.G. Sciotto, and M.M. O'Brien Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus Laryngoscope 117 2007 2115 2128 (Pubitemid 351339584)
5. C.C.R. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis Int J Cancer 121 2007 1813 1820 (Pubitemid 47417302)
6. S. Syrjanen HPV infections and tonsillar carcinoma J Clin Pathol 57 2004 449 455 (Pubitemid 38621787)
7. D.J. Haraf, E. Nodzenski, and D. Brachman Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival Clin Cancer Res 2 1996 755 762 (Pubitemid 26133472)
8. K. Syrjanen, S. Syrjanen, and M. Lamberg Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous-cell carcinogenesis Int J Oral Surg 12 1983 418 424 (Pubitemid 14141093)
9. B.J.M. Braakhuis, P.J.F. Snijders, and W.J.H. Keune Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 2004 998 1006 (Pubitemid 39162642)
10. K.M. Applebaum, C.S. Furniss, and A. Zeka Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer J Natl Cancer Inst 99 2007 1801 1810 (Pubitemid 351767210)
11. R. Herrero, X. Castellsague, and M. Pawlita Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783 (Pubitemid 38008900)
12. C.G.L. Hobbs, J.A.C. Sterne, and M. Bailey Human papillomavirus and head and neck cancer: A systematic review and meta-analysis Clin Otolaryngol 31 2006 259 266 (Pubitemid 44141088)
13. C.C.R. Ragin, F. Modugno, and S.M. Gollin The epidemiology and risk factors of head and neck cancer: A focus on human papillomavirus J Dent Res 86 2007 104 114
14. S.H. Kim, B.S. Koo, and S. Kang HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation Int J Cancer 120 2007 1418 1425 (Pubitemid 46355375)
15. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269 (Pubitemid 351480538)
16. S. Begum, and W.H. Westra Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status Am J Surg Pathol 32 2008 1044 1050
17. A.R. Sedaghat, Z. Zhang, and S. Begum Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas Laryngoscope 119 2009 1542 1549
18. F.P. Worden, B. Kumar, and J.S. Lee Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
19. M. Benevolo, M. Mottolese, and F. Marandino Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions Mod Pathol 19 2006 384 391 (Pubitemid 43276992)
20. K.T. Kuo, C.H. Hsiao, and C.H. Lin The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma - Molecular basis and predicting favorable outcome Mod Pathol 21 2008 376 386
21. W. Shi, H. Kato, and B. Perez-Ordonez Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma J Clin Oncol 27 2009 6213 6221
22. K. Lindel, K.T. Beer, and J. Laissue Human papillomavirus positive squamous cell carcinoma of the oropharynx - A radiosensitive subgroup of head and neck carcinoma Cancer 92 2001 805 813 (Pubitemid 32783066)
23. L.H. Gray, A.D. Conger, and M. Ebert The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 1953 638 648
24. B. Kumar, K.G. Cordell, and J.S. Lee Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking Int J Radiat Oncol Biol Phys 69 2007 S109 S111
25. H.L. Janssen, K.M. Haustermans, and A.J. Balm Hypoxia in head and neck cancer: How much, how important? Head Neck 27 2005 622 638 (Pubitemid 40961072)
26. Q.T. Le, C. Kong, and P.W. Lavori Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 69 2007 167 175 (Pubitemid 47247510)
27. I.J. Hoogsteen, H.A.M. Marres, and J. Bussink Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A review Head Neck 29 2007 591 604 (Pubitemid 47324777)
28. P. Mellanen, H. Minn, and R. Grenman Expression of glucose transporters in head-and-neck tumors Int J Cancer 56 1994 622 629 (Pubitemid 24086761)
29. B.S. Sorensen, J. Hao, and J. Overgaard Influence of oxygen concentration and pH on expression of hypoxia induced genes Radiother Oncol 76 2005 187 193 (Pubitemid 41725446)
30. V. Nizet, and R.S. Johnson Interdependence of hypoxic and innate immune responses Nat Rev Immunol 9 2009 609 617
31. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24 (Pubitemid 41503384)
32. M. Nordsmark, J.G. Eriksen, and V. Gebski Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients Radiother Oncol 83 2007 389 397 (Pubitemid 46907981)
33. J.G. Eriksen, and J. Overgaard Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study Radiother Oncol 83 2007 383 388 (Pubitemid 46907987)
34. J. Overgaard, J.G. Eriksen, and M. Nordsmark Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: Results from the DAHANCA 5 randomised double-blind placebo-controlled trial Lancet Oncol 6 2005 757 764 (Pubitemid 41430716)
35. M.I. Koukourakis, A. Giatromanolaki, and E. Sivridis Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy Clin Cancer Res 7 2001 3399 3403 (Pubitemid 33069972)
36. G. Finak, N. Bertos, and F. Pepin Stromal gene expression predicts clinical outcome in breast cancer Nat Med 14 2008 518 527 (Pubitemid 351655218)
37. A.H.G. Cleven, B.G. Wouters, and B. Schutte Poorer outcome in stromal HIF-2[alpha]- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis Br J Cancer 99 2008 727 733
38. H. Lau, S. Brar, and D. Hao Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity Head Neck 28 2006 189 196 (Pubitemid 43269884)
39. H.Y. Lau, S. Brar, and A.C. Klimowicz Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy Head Neck 33 2011 251 256
40. R.L. Camp, G.G. Chung, and D.L. Rimm Automated subcellular localization and quantification of protein expression in tissue microarrays Nat Med 8 2002 1323 1327 (Pubitemid 35373567)
41. E.L. Kaplan, and P. Meier Nonparametric-estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
42. C.S. Kong, B. Narasimhan, and H. Cao The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
43. N. Robertson, C. Potter, and A.L. Harris Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion Cancer Res 64 2004 6160 6165 (Pubitemid 39129417)
44. S. Ivanov, S.Y. Liao, and A. Ivanova Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer Am J Pathol 158 2001 905 919 (Pubitemid 32221783)
45. I.J. Hoogsteen, H.A. Marres, and K.I. Wijffels Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma Clin Cancer Res 11 2005 97 106 (Pubitemid 40075783)
46. Q. Shi, X.D. Le, and B.L. Wang Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells Oncogene 20 2001 3751 3756 (Pubitemid 32624967)
47. R.A. Gatenby, and R.J. Gillies A microenvironmental model of carcinogenesis Nat Rev Cancer 8 2008 56 61
48. E. Svastova, N. Zilka, and M. Zat'ovicova Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin Exp Cell Res 290 2003 332 345 (Pubitemid 37272176)
49. S. Parkkila, H. Rajaniemi, and A.K. Parkkila Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro Proc Natl Acad Sci U S A 97 2000 2220 2224 (Pubitemid 30134049)
50. H.M. Sowter, R.R. Raval, and J.W. Moore Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia Cancer Res 63 2003 6130 6134 (Pubitemid 37255150)
51. C.J. Hu, S. Iyer, and A. Sataur Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1 alpha) and HIF-2 alpha in stem cells Mol Cell Biol 26 2006 3514 3526
52. S.Y. Liao, M.I. Lerman, and E.J. Stanbridge Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development BMC Dev Biol 9 2009 22
53. E.P. Cummins, and C.T. Taylor Hypoxia-responsive transcription factors Pflugers Arch 450 2005 363 371 (Pubitemid 41380694)
54. S. Kaluz, M. Kaluzova, and E.J. Stanbridge Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer Cancer Res 63 2003 917 922 (Pubitemid 36278419)
55. K. Salnikow, O. Aprelikova, and S. Ivanov Regulation of hypoxia-inducible genes by ETS1 transcription factor Carcinogenesis 29 2008 1493 1499
56. J. Chiche, K. Ilc, and J. Laferriere Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH Cancer Res 69 2009 358 368
57. K. Mekhail, L. Gunaratnam, and M.E. Bonicalzi HIF activation by pH-dependent nucleolar sequestration of VHL Nat Cell Biol 6 2004 642 647 (Pubitemid 38960922)
58. E.M. Smith, D. Wang, and Y. Kim p16(INK4a) expression, human papillomavirus, and survival in head and neck cancer Oral Oncol 44 2008 133 142 (Pubitemid 351179656)
59. A.K. Lie, B. Risberg, and B. Borge DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia Gynecol Oncol 97 2005 908 915 (Pubitemid 40824665)
60. A.S. Zinkernagel, R.S. Johnson, and V. Nizet Hypoxia inducible factor (HIF) function in innate immunity and infection J Mol Med 85 2007 1339 1346 (Pubitemid 350234101)
61. C.H. Chung, S. Levy, and W.G. Yarbrough Clinical applications of genomics in head and neck cancer Head Neck 28 2006 360 368
62. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit Effect of HPV-associated p16(INK4A) expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
63. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
64. A. Hunter, A. Hendrikse, and M. Renan Does the tumor microenvironment influence radiation-induced apoptosis? Apoptosis 11 2006 1727 1735 (Pubitemid 44371048)
65. J.M. Brown, and W.R. William Exploiting tumour hypoxia in cancer treatment Nat Rev Cancer 4 2004 437 447 (Pubitemid 38745529)
66. B.J. Moeller, R.A. Richardson, and M.W. Dewhirst Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment Cancer Metastasis Rev 26 2007 241 248 (Pubitemid 47101661)
67. R. Corvo Evidence-based radiation oncology in head and neck squamous cell carcinoma Radiother Oncol 85 2007 156 170 (Pubitemid 47562578)